43 reports

One unit refers to one Mycobacterium Diagnostic test.

  • Tuberculosis
  • Australasia
  • Demand
  • Market Size
  • Supply

Tuberculosis remains the world' s biggest infectious disease killer, claiming ##. ## million lives in 2016.

  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • United Kingdom

Immunotherapy; ##(##): ##-##.

  • Tuberculosis
  • Market Size
  • Actelion Ltd
  • Bristol-Myers Squibb Company
  • Pfizer Inc.

" Despite steady progress in reducing the burden of tuberculosis in recent decades, TB remains a major global health problem and one of the top ## causes of death worldwide, " said Dr.

  • Tuberculosis
  • United Kingdom
  • DENTSPLY Sirona Inc.
  • Ivoclar Vivadent AG
  • Kuraray Noritake Dental Inc.

CLINICAL TRIALS BY PHASE IN E## COUNTRIES TUBERCULOSIS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* TUBERCULOSIS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* Country Name Phase IV Phase III/ IV Phase III Phase II/ III Phase II Phase I/ II Ph

  • Monoclonal Antibody
  • Pharmaceutical
  • Tuberculosis
  • World
  • Product Initiative

PULMONARY TUBERCULOSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PULMONARY TUBERCULOSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PULMONARY TUBERCULOSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018*

  • Clinical Trial
  • Immunotherapy
  • Tuberculosis
  • World
  • Product Initiative

MYCOBACTERIUM TUBERCULOSIS INFECTIONS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CLINICAL TRIALS BY PHASE IN E## COUNTRIES MYCOBACTERIUM TUBERCULOSIS INFECTIONS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* MYCOBACTERIUM TUBERCULOSIS INFECTION

  • Clinical Trial
  • Drug Development
  • Infectious Disease
  • Tuberculosis
  • World

Steven Reed, IDRI founder and chief scientific officer, said, " Tuberculosis is one of the most widespread, persistent and deadly global health problems.

  • Pathology
  • Pharmaceutical
  • Tuberculosis
  • Vaccine
  • World

The prominent features of this report are - ##.

  • Clinical Trial
  • Pharmaceutical
  • Tuberculosis
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World

One of these preclinical compounds NITD##, blocks MmpL##, a protein essential for the TB bacterium' s survival.

  • Pathology
  • Tuberculosis
  • World
  • Company
  • TB Drug Development, Inc.

Our system has the potential to drive major advances in rapid diagnosis of immunologically complex conditions such as tuberculosis. "

  • Diagnostics
  • Tuberculosis
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.

The remaining ##% of the tuberculosis pipeline consists of four proteins, two peptides and one oligonucleotide.

  • Anti-Infective
  • Infectious Disease
  • Therapy
  • Tuberculosis
  • Deals & Alliance

This agreement enables Janssen Pharma and FIND to accelerate access to tuberculosis (TB) diagnosis, treatment and care.

  • Tuberculosis
  • Belgium
  • United States
  • Company
  • Janssen Biotech, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Monoclonal Antibody
  • Pharmaceutical
  • Tuberculosis
  • World

SQ## could replace one or more of the current TB drugs, simplify therapy, and shorten current treatment time.

  • Tuberculosis
  • Russia
  • United States
  • Deals & Alliance
  • Pfizer Inc.

Under the research protocol, breath samples will be collected from patients with COPD, as well as two comparison groups: one comprising individuals who are healthy, and one comprising patients recently diagnosed with lung cancer.

  • Breast Cancer
  • Diabetes
  • Tuberculosis
  • United States
  • Menssana Research Inc.

Tuberculosis ## Varicella-zoster Virus Infection ## Herpes Simplex Virus ## Infection ## Herpes Simplex Virus ## Infection ## Human Herpes Virus ## Infection ## Infectious Diseases ## Influenza A Virus Infection ## Influenza B Virus Infection ## Influenza I

  • Molecular Diagnostics
  • Tuberculosis
  • United States
  • Company
  • Akonni Biosystems, Inc.

Each unit is expected to be comprised of one common share of the Emerge Resources and one common share purchase warrant.

  • Pharmaceutical
  • Tuberculosis
  • Israel
  • Company
  • Vaxil

" Q## is undergoing intensive phase ## testing and demonstrates excellent results in all studies, including one that is completed by our partner Infectex", - said Dr.

  • Healthcare
  • Pharmaceutical
  • Tuberculosis
  • South Korea
  • Qurient Co., Ltd.

Promising results in early clinical studies have been seen in tuberculosis and cystic fibrosis.

  • Pathology
  • Tuberculosis
  • United States
  • Product Initiative
  • Avisa Pharma Inc.

It' s estimated that up to one-third of the world' s population is infected with M. tuberculosis, the bacterium that causes TB.

  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • United States
  • Company

This system will help us speed up the process of finding treatments and vaccines for human tuberculosis, an infection that kills ##. ## million people per year. "

  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • United Kingdom
  • BioInvent

" Tuberculosis is a global public health threat, particularly with multi-drug resistant TB strains on the rise, " said GNA Biosolutions Managing Director Lars Ullerich.

  • Biotech Diagnostics
  • Diagnostics
  • Tuberculosis
  • Company
  • Product Initiative

One of the main antibiotics for TB is rifampicin, however, many strains of the Tuberculosis-causing bacteria - Mycobacterium tuberculosis have developed resistance to it.

  • Cancer
  • Therapy
  • Tuberculosis
  • United Kingdom
  • Deals & Alliance

Tuberculosis ## Viral Infections ## Human Papilloma Virus Infection ## John Cunningham Virus Infection ## Leishmaniasis ## Liver Cancer ## Lung Cancer ## Lyme Disease ## Malaria ## Melanoma ## Pancreatic Cancer

  • DNA
  • Tuberculosis
  • United States
  • Company
  • Trovagene, Inc.

Tuberculosis ## Type I Diabetes Mellitus ## Chlamydia Trachomatis Infection ## Hepatitis C Infection ## Human Immunodeficiency Virus Infection ## Human Immunodeficiency Virus Type ## Infection ## Influenza A Virus Infection ## Liver Can

  • Hepatitis
  • Tuberculosis
  • United States
  • Company
  • Product Initiative

GlobalData Oxford Immunotec Ltd, reported one medical equipment deal worth $## million in YTD 2018.

  • Tuberculosis
  • United States
  • Company
  • Company Financials
  • Market Size

In addition, one study evaluates a new combination of existing antibiotics to treat pulmonary tuberculosis (TB), including multidrug-resistant TB.

  • Cancer
  • Therapy
  • Tuberculosis
  • United States
  • MetaStat, Inc.

Sequella retains all rights to commercialize B-Smart technology worldwide for indications other than tuberculosis, and for territories other than the US for tuberculosis.

  • Pathology
  • Tuberculosis
  • United States
  • Deals & Alliance